AXA SA (1CS) Fair Value & Analysis
Financial Services · IT · Market cap €89.1B
Fair value as of: Jul 3, 2026
From 19 valuation models · updated today
Share price +11.9% over the past month.
Price vs Fair Value (12 months)
12‑month range €35.54 – €44.32 · fair‑value band €50.57 – €84.28 · the €44.03 price screens below the €67.43 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
AXA SA (1CS) currently trades at €44.03, while our model-based Fair Value estimate is €67.43 — implying the stock looks roughly 53.1% undervalued today. We read business quality at 67/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, AXA SA generated revenue of €94.7B at a net margin of 10.4%. Revenue grew 3.2% year over year. It earns a return on equity of 13.4%. Net debt stands at €38.2B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
AXA SA, through its subsidiaries, insurance, asset management, and banking services worldwide. The company operates through France, Europe, AXA XL, Asia, Africa & EME-LATAM, and Transversal & Other segments. It offers life and savings insurance and property and casualty insurance products. The company also provides protection and retirement products for individual and professional customers; reinsurance coverages; property, primary and excess casualty, excess and surplus lines, environmental liability, professional liability, construction, marine, energy, aviation and satellite, fine art and specie, livestock and aquaculture, accident and health, and crisis management. In addition, it offers reinsurance solutions with casualty, property risk, property catastrophe, specialty, and other reinsurance; proportional and non-proportional, and facultative reinsurance; risk management solutions and consulting services; integrated ecosystem between healthcare solutions and the insurance …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
AXA SA reported revenue of €106B in FY2025 versus €112B in FY2021, a compound −1.3%/yr. Reported net income was €9.8B in FY2025, compounding +7.7%/yr from FY2021.
Is 1CS fairly valued? → Check now
Recent news
- BOE Sees Weather as New Inflation Risk While London Sizzles
- AXA Wins 7 Accolades at Bloomberg Businessweek Financial Institutions Awards 2026
- AXA Week for Good 2026 Successfully Concludes Harnessing Technology and Community Engagement to Promote Biodiversity and Social Inclusion
- Investor Who Scored 900% Win in 2008 Crisis Has New Big Short Bet
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
6 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Berkshire Hathaway Inc BRK | C$35.75 | C$32.35 | -10% |
| Allianz SE 1ALV | €420.00 | €397.72 | -5% |
| Zurich Insurance Group ZURVY | $36.15 | $29.58 | -18% |
| Assicurazioni Generali S.p.A ARZGY | $24.41 | $28.91 | +18% |
| Sun Life Financial Inc SLF | $77.66 | $56.68 | -27% |
| American International Group AIGB34 | R$397.02 | R$91.86 | -77% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is AXA SA (1CS) undervalued?
What is the fair value of 1CS?
What is the quality score of 1CS?
What is the revenue of AXA SA (1CS)?
What is the net profit margin of 1CS?
Does AXA SA pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.